Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Entera Bio Ltd. (ENTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21
   10-Q10-K10-Q10-Q10-Q10-K
REVENUES   0.10.30.40.50.6
            REVENUES growth   -76.5%    
COST OF REVENUES   0.10.20.30.40.4
    GROSS PROFIT   0.00.10.10.10.2
            Gross margin   24.6%19.6%30.9%26.6%34.7%
   
OPERATING EXPENSES:        
Research and development   5.87.17.57.36.8
General and administrative   7.37.07.16.65.7
Other income   -0.10.0-0.10.00.0
    TOTAL OPERATING EXPENSES   18.520.521.420.020.0
OPERATING LOSS   13.014.014.413.712.2
            Operating margin   -9714.2%-4925.3%-3451.3%-2845.0%-2139.6%
FINANCIAL INCOME, NET   -0.1-0.1-0.10.00.0
LOSS BEFORE INCOME TAX   12.914.014.313.712.2
INCOME TAX BENEFIT   0.10.20.0-0.1-0.1
NET LOSS   13.114.114.313.712.2
   
LOSS PER SHARE BASIC   $0.45$0.50$0.50$0.49$0.46
LOSS PER SHARE DILUTED   $0.45$0.50$0.50$0.49$0.46
   
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE   28.828.128.127.125.4
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE   21.620.920.9 19.9

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy